This stock meets the investing criteria of the Fidelity Magellan Fund's legendary manager.
The two drug companies end a rocky 10-year partnership. What's next for Amylin?
Although these stocks are based in Europe, they should be viewed as global powerhouses.
Abbott Labs, CME Group and Occidental Petroleum score as quality stocks with low price-to-book value ratios.
Buy any one of these mutual funds and sleep tight at night.
The pharma giant is successfully re-energizing its drug pipeline to counteract patent expirations.
A diversified portfolio and a high credit rating make this health care leader a defensive favorite.
These dividend-paying stocks appear undervalued relative to their long-term appreciation potential.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
The Fed may start tapering in just a few months. Here are a few of the likely winners and losers.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Even those who don't like to shop are probably hitting the stores this month. Here's what to be on the lookout for and here's what to avoid.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.